Skip to content

908 Devices MASS Free cash flow yield

Free cash flow yield at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.7%+0.1pp
WAT
Waters CorporationWAT
0.9%-1.9pp
Agilent Technologies logo
Agilent TechnologiesA
3.3%-0.6pp
Bruker logo
BrukerBRKR
0.9%-1.8pp
Mettler-Toledo International, Inc. logo
Mettler-Toledo International, Inc.MTD
3.1%-0.4pp
Danaher logo
DanaherDHR
3.9%+0.6pp

Other financials

Income statement

See full
Revenue$13.4M+13.6%
Gross profit$6.9M+24.2%
Operating income-$12.9M-16.9%
Net income-$12.0M-127%
EPS (diluted)-$0.32-126%

Balance sheet

See full
Cash & equivalents$67.6M-14.7%
Total debt$4.5M+18.6%
Total equity$134.2M-15.8%
Total assets$186.7M-4.8%

Cash flow

See full
Operating cash flow$1.2M+108%
CapEx$40.0K-74.8%
Free cash flow$1.2M+108%

Valuation

See full
Market cap$339.57M+29.0%
Enterprise value$276.47M+47.2%
P/S5.9×+0.8×

Profitability

See full
Gross margin51.5%+1.3pp
Operating margin-76.8%-19.6pp
Net margin-62.4%+323pp
FCF margin-16.7%-7.2pp

Returns & leverage

See full
Return on equity-24.6%-149pp
Debt / equity0.0×
Current ratio3.6×-4.0×

Where this comes from

Calculated from 908 Devices’s reported figures.

Based on trailing twelve months.

The official record: 908 Devices’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about 908 Devices's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 908 Devices's free cash flow yield?
908 Devices (MASS) reported free cash flow yield of -4.2% in Q1 2026.
How has 908 Devices's free cash flow yield changed year-over-year?
908 Devices's free cash flow yield increased by 81.4% year-over-year, from -22.6% to -4.2%.
What is the long-term trend for 908 Devices's free cash flow yield?
Over 5 years (2020 to 2025), 908 Devices's free cash flow yield has grown at a 120.0% compound annual growth rate (CAGR), from 0.3% to -13.7%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.